Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3382 of 6351
-
Old gout drug tested as new hope for advanced liver cancer
Disease control CompletedThis trial is to evaluate the palliative effects of colchicine on primary hepatic malignancy using the Department of Health R.O.C. approved doses and methods of administration. Colchicine will be started from 2 tablets after meal twice per day (total 2 mg), adjust the dose rangin…
Phase 2 • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:59 UTC
-
New combo therapy for AML enters early human testing
Disease control OngoingThe purpose of the study is to characterize safety and tolerability of cusatuzumab in combination with various therapies used to treat acute myeloid leukemia (AML).
Phase 1 • Sponsor: OncoVerity, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Prenatal DNA test may uncover Mom's cancer risk
Knowledge-focused Recruiting nowBackground: Pregnant women can get a DNA analysis of their blood. The test tells a woman and her doctor about the DNA of her unborn baby. But some women get test results that are abnormal or not reportable. Researchers want to learn more about the relationship between these test…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis is an open-label, Phase I, first-in-human (FIH) multicenter, clinical study conducted in multiple parts to establish the safety, tolerability and pharmacokinetic/pharmacodynamic (PK/PD) profile (with and without food) and early signs of efficacy of Tuvuseritib (M1774) as mon…
Phase 1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New pain program aims to help veterans take control of chronic pain
Symptom relief CompletedTo conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA) Cognitive Behavioral Therapy Chronic Pain (CBT-CP)
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New program tackles smoking in HIV by easing anxiety and depression
Symptom relief CompletedSmokers living with HIV represent a major health disparity population in the United States and the world more generally. Major contributing factors to the maintenance and relapse of smoking among smokers living with HIV include increased exposure to multiple stressors associated …
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Fish oil may counteract hidden diabetes risk from low bad cholesterol
Knowledge-focused Recruiting nowEvery 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk factors such as aging, obesity and unhealthy lifestyle. Paradoxically however, while lowering blood LDL…
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Can an asthma drug soothe skin allergies? small trial tests dupilumab
Disease control OngoingThe aim of this study is to investigate the effects of dupilumab on allergic contact dermatitis.
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a genetic test predict hidden cancer spread? new study uses advanced scans to find out
Knowledge-focused Recruiting nowThis study will enroll 60 patients previously enrolled to MCC#18523, "A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non-African American Men with Prostate Cancer: (VANDAAM)" that had high risk Decipher test results (Dec…
Phase 2/3 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New program helps men fight prostate cancer side effects
Symptom relief CompletedEach year over 20,000 men are diagnosed with prostate cancer in Canada with the majority undergoing some form of treatment option. Radical prostatectomy and/or radiation therapy are common procedures that are effective in the treatment of prostate cancer. However, they typically …
Sponsor: Nova Scotia Health Authority • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Scientists build cellular map of Crohn's gut to find new clues
Knowledge-focused OngoingInflammatory bowel disease (IBD), consisting of two major forms, Crohn's disease (CD) and ulcerative colitis, affects more than 1.6 million people in the United States alone. Despite current therapies, remission only occurs in approximately half of patients. The goal of study is …
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New tool aims to give voice to childhood cancer Survivors' Long-Term symptoms
Knowledge-focused OngoingChildhood cancer survivors are vulnerable to treatment-related late effects, including physical and psychosocial morbidities, subsequent malignancies, and premature death. Symptom assessment provides a unique insight into survivorship care since symptoms not only indicate the man…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Chocolate compound fights teen obesity?
Disease control CompletedChildhood obesity is a serious public health problem internationally. In addition to being associated with the early onset of chronic degenerative diseases such as diabetes, dyslipidemias, coronary artery diseases, among others. Changes in lifestyle habits are the main axis in t…
Sponsor: National Polytechnic Institute, Mexico • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Teens with NF try video coaching to boost mood and health
Symptom relief CompletedThis randomized controlled trial for resiliency training in adolescents with Neurofibromatosis 1 and Neurofibromatosis 2 via secure live video to determine the efficacy two stress and symptom management programs. Both programs are 8 week group programs.
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New drug shows promise against superbug fungus in small trial
Disease control CompletedThis is a multicenter, open-label, single arm study to evaluate the efficacy and safety of APX001 for the treatment of candidemia and/or invasive candidiasis caused by C. auris in patients aged 18 years and over with limited antifungal treatment options.
Phase 2 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jun 26, 2026 17:48 UTC
-
Can a simple breathing test predict sudden death in epilepsy?
Knowledge-focused Recruiting nowThe purpose of this research study is to better understand what causes Sudden Unexpected Death in Epilepsy (SUDEP). This study will enroll subjects from the University of Iowa Hospitals and Clinics (UIHC) Epilepsy Monitoring Unit (EMU) and Epilepsy Clinics. The investigators will…
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo aims to shrink rectal tumors before surgery
Disease control CompletedThis phase 1b trial studies the side effects and best dose of TAS-102 when given together with radiation therapy in treating patients with stage II-III rectal cancer that has not been treated and can be removed by surgery (resectable). Drugs used in chemotherapy, such as TAS-102,…
Phase 1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New visual trick may boost arm recovery after stroke
Symptom relief Recruiting nowHemiparesis is a common motor disorder after a stroke. The majority of patients do not recover functional use of their paretic upper limb. The use of mirror therapy allows the activation of the mirror neurons involved to stimulate brain plasticity after brain damage.The IVS (Int…
Sponsor: Clinique Les Trois Soleils • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New antibody combo aims to supercharge immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis is a Phase 1/2, open-label, non-randomized, 4-part trial to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX 106 administered as a single agent or in combination with the anti-PD-1 checkpoint inhibitor…
Phase 1/2 • Sponsor: Inhibrx Biosciences, Inc • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Heart scans without X-Rays: a safer way to check Kids' hearts
Knowledge-focused CompletedOverall Research Strategy of this protocol is to refine and validate noninvasive CMR imaging sequences with invasive hemodynamic and pathology results to create a comprehensive, noninvasive, radiation-reduced regimen for pediatric cardiomyopathy and cardiac transplant assessment.…
Sponsor: Children's National Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC